The combination of mXO10 tLNP@mIDH1 mRNA vaccine and Anti-PD-1 had an even greater effect, increasing the number of CD3+CD8+IFN-γ+ T cells in glioma tissue by approximately 4.4 times compared to the control group. The gene discussed is IFNG; the disease is central nervous system cancer.